Background: The leaves of Chenopodium ambrosioides L. (Chenopodiaceae) are widely used in Moroccan traditional medicine to treat diabetes and hypertension. The goal of the present work is to investigate the hypotensive properties of different extract and fractions of the plant in anesthetized normotensive rats and to elucidate the mechanism underlying this effect.Methods: The hypotensive effect of aqueous extract (AqE) of the leaves of C. ambrosioides L., methanolic (MF), ethyl acetate (AcF), and aqueous (AqF) Soxhlet fractions, administrated intravenously, was evaluated in anesthetized rats. The recorded signals of blood pressure and heart rate were visualized and analyzed by using an acquisition card “National Instrument” and software Labview 6.1.Results: Intravenous administration of AqE of the leaves of C. ambrosioides L. induces a dose-dependent hypotension. A similar effect was obtained with MF, AcF, and AqF. Atropine (1 mg/kg), used to block cholinergic system, significantly reduced the hypotensive response to MF and AcF suggesting the presence of the cholinomimetic–muscarinic components in these fractions. However, the blood pressure lowering effect of MF and AcF in rats pretreated with L-NAME 20 mg/kg was unchanged showing that the release of NO is not implicated in the hypotensive action of this plant.Conclusions: The present study demonstrates that extracts from leaves of C. ambrosioides induce hypotensive effect that may be partially associated with its cardiac effects. These results may partly explain the traditional use of leaves of C. ambrosioides L. for the treatment of disorders such as hypertension.
We express our thanks to Mrs. Mostafa Badraoui and Karim Ramdaoui from our laboratory for the reliable care of animals breeding. This work was supported by grants from CNRST, Morocco [Project URAC-40] and from Belgium [Program 3, CUD Project].
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research funding played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
1. ZiyyatA, LegssyerA, MekhfiH, DassouliA, SerhrouchniM, BenjellounW. Phytotherapy of hypertension and diabetes in oriental morocco. J Ethnopharmacol1997;58:45–54.10.1016/S0378-8741(97)00077-9Search in Google Scholar
2. EddouksM, MaghraniM, LemhadriA, OuahidiML, JouadH. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of morocco (tafilalet). J Ethnopharmacol2002;82:97–103.10.1016/S0378-8741(02)00164-2Search in Google Scholar
3. TahraouiA, El-HilalyJ, IsrailiZH, LyoussiB. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern morocco (Errachidia province). J Ethnopharmacol2007;110:105–17.10.1016/j.jep.2006.09.011Search in Google Scholar
4. TrivellatoGrassiL, MalheirosA, Meyre-SilvaC, Buss ZdaS, MonguilhottED, FrödeTS, et al. From popular use to pharmacological validation: a study of the anti-inflammatory, anti-nociceptive and healing effects of Chenopodium ambrosioides extract. J Ethnopharmacol2013;145:127–38.10.1016/j.jep.2012.10.040Search in Google Scholar
5. JardimCM, JhamGN, DhingrabOD, FreireaMM. Chemical composition and antifungal activity of the hexane extract of the Brazilian Chenopodium ambrosioides L. J Braz Chem Soc2010;21:1814–18.10.1590/S0103-50532010001000004Search in Google Scholar
6. KumarR, MishraAK, DubeyNK, TripathiYB. Evaluation of Chenopodium ambrosioides oil as a potential source of antifungal, antiaflatoxigenic and antioxidant activity. Int J Food Microbiol2007;115:159–64.10.1016/j.ijfoodmicro.2006.10.017Search in Google Scholar
7. JamaliA, KouhilaM, Ait MohamedL, JaouhariJT, IdlimamA, AbdenouriN. Sorption isotherms of Chenopodium ambrosioides leaves at three temperature. J of Food Eng2006;72:77–84.10.1016/j.jfoodeng.2004.11.021Search in Google Scholar
8. BellakhdarJ. La pharmacopée marocaine traditionnelle: médecine arabe et savoirs populaires. Editions le Fennec, Ibis Press, Casablanca, Morocco, 1997:640.Search in Google Scholar
9. HallalA, BenaliS, MarkoukM, BekkoucheK, LarhsiniM, ChaitA, et al. Evaluation of the analgesic and antipyretic activities of Chenopodium ambrosioides L. Asian J Exp Biol Sci2010;1:189–92.Search in Google Scholar
10. CalzadaF, AristaR, PérezH. Effect of plants used in Mexico to treat gastrointestinal disorders on charcoal-gum acacia-induced hyperperistalsis in rats. J Ethnopharmacol2010;128:49–51.10.1016/j.jep.2009.12.022Search in Google Scholar
11. NascimentoFR, CruzGV, PereiraPV, MacielMC, SilvaLA, AzevedoAP, et al. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. Treat Life Sci2006;78:2650–3.10.1016/j.lfs.2005.10.006Search in Google Scholar
12. HmamouchiM, LahlouM, AgoumiA. Molluscicidal activity of some Moroccan medicinal plants. Fitoterapia2000;71:308–14.10.1016/S0367-326X(99)00152-5Search in Google Scholar
13. ZhuWX, ZhaoK, ChuSS, LiuZL. Evaluation of essential oil and its three main active ingredients of Chinese Chenopodium ambrosioides (Family: Chenopodiaceae) against Blattella germanica. J Arthropod Borne Dis2012;6:90–7.Search in Google Scholar
14. Di CarloG, MascoloN, IzzoAA, CapassaoF. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci1999;65:337–53.10.1016/S0024-3205(99)00120-4Search in Google Scholar
15. KiuchiF, ItanoY, UchiyamaN, HondaG, TsubouchiA, Nakajima-ShimadaJ, et al. Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J Nat Prod2002;65:509–12.10.1021/np010445gSearch in Google Scholar
16. LiuRH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr2004;134:3479–85.10.1093/jn/134.12.3479SSearch in Google Scholar
17. NeeruJ, Sarwar AlamM, KamilM, IlyasM, NiwaM, SakaeA. Two flavonol glycosides from Chenopodium ambrosioides. Phytochemistry1990;29:3988–91.10.1016/0031-9422(90)85389-WSearch in Google Scholar
18. GoharAA, ElmazarMM. Isolation of hypotensive flavonoids from Chenopodium species growing in Egypt. Phytother Res1997;11:564–7.10.1002/(SICI)1099-1573(199712)11:8<564::AID-PTR162>3.0.CO;2-LSearch in Google Scholar
19. MohanRM, PatersonDJ. Activation of sulphonylurea-sensitive channels and the NO–cGMP pathway decreases the heart rate response to sympathetic nerve stimulation. Cardiovasc Res2000;47:81–9.10.1016/S0008-6363(00)00057-2Search in Google Scholar
20. ThrasherTN. Baroreceptors and the long-term control of blood pressure. Exp Physiol2004;84:331–41.10.1113/expphysiol.2004.027441Search in Google Scholar
21. BernardesMJ, de CarvalhoFS, Lima SilveiraL, de PaulaJR, BaraMT, GarroteCF, et al. Hypotensive effect of Aspidosperma subincanum Mart. In rats and its mechanism of vasorelaxation in isolated arteries. J Ethnopharmacol2013;145:227–32.10.1016/j.jep.2012.10.057Search in Google Scholar
22. AdeneyeAA, AjagbonnaOP, MojiminiyiFB, OdigieIP, OjoborPD, EtarrhRR, et al. The hypotensive mechanisms for the aqueous stem bark extract of Musanga cecropioides in Sprague–Dawley rats. J Ethnopharmacol2006;106:203–7.10.1016/j.jep.2005.12.023Search in Google Scholar
23. KouakouLK, AboKJ, TraoreF, EhileE. Effect antihypertensif de BpF2, une fraction d’extrait aqueux de feuilles de bidens pilosa L. (Asteraceae) chez le lapin. Sci Nat2008;5:29–37.10.4314/scinat.v5i1.42149Search in Google Scholar
24. NguelefackTB, MekhfiH, DimoT, AfkirS, Nguelefack-MbuyoEP, LegssyerA, et al. Cardiovascular and anti-platelet aggregation activities of extracts from Solanum torvum (Solanaceae) fruits in rat. J Complement Integr Med2008;5:1553–3840.10.2202/1553-3840.1105Search in Google Scholar
25. DheinS, van KoppenCJ, BroddeOE. Muscarinic receptors in the mammalian heart. Pharmacol Res2001;44:161–82.10.1006/phrs.2001.0835Search in Google Scholar PubMed
26. LoffelholzK, PappanoAJ. The parasympathetic neuroeffector junction of the heart. Pharmacol Rev1985;37:1–24.Search in Google Scholar
27. KentKM, EpsteinSE, CooperT, JacobowitzDM. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation1974;50:948–55.10.1161/01.CIR.50.5.948Search in Google Scholar
28. NagataK, YeC, JainM, MilstoneDS, LiaoR, MortensenRM. Galpha (i2) but not Galpha (i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes. Circ Res2000;87:903–9.10.1161/01.RES.87.10.903Search in Google Scholar
©2014 by Walter de Gruyter Berlin / Boston